kabutan

DAIKEN MEDICAL, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 6%

Fri Jan 31, 2025 4:00 pm JST Earnings

7775 DAIKEN MEDICAL CO.,LTD. 【J-GAAP】

Earnings Report

DAIKEN MEDICAL CO.,LTD <7775> [TSE Std] announced its financial results after the market closed on January 31st (16:00). The ordinary profit (non-consolidated) for the cumulative third quarter of the fiscal year ending March 2025 (April to December) increased 5.9% from the same period last year, reaching 1.31 billion yen. The progress rate toward the full-year plan of 1.5 billion yen was 87.7%, almost the same as the five-year average of 86.2%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary profit for the January to March period (4Q) is expected to decrease 11.1% from the same period last year to 0.18 billion yen.

In the most recent three-month period, from October to December (3Q), the ordinary profit amounted to 0.47 billion yen, a 2.6% decrease compared to the same period last year. The operating profit margin decreased from 19.1% in the same period last year to 17.4%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2022 6,896 969 968 688 24.0 91.9 Jan 31, 2023 J-GAAP
Apr - Dec, 2023 7,406 1,237 1,242 888 30.9 85.7 Jan 31, 2024 J-GAAP
Apr - Dec, 2024 7,665 1,315 1,315 957 33.3 87.7 Jan 31, 2025 J-GAAP
YoY +3.5% +6.3% +5.9% +7.8% +7.8%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 4,926 697 700 451 15.7 12 May 15, 2024 J-GAAP
Oct - Mar, 2024 Guidance 5,186 664 664 422 14.7 13 Oct 31, 2024 J-GAAP
YoY +5.3% -4.7% -5.1% -6.4% -6.5%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 9,137 1,054 1,053 712 24.8 20 May 15, 2023 J-GAAP
Mar, 2024 9,750 1,442 1,450 988 34.4 21 May 15, 2024 J-GAAP
Mar, 2025 Guidance 10,100 1,500 1,500 1,030 35.9 22 May 15, 2024 J-GAAP
YoY +3.6% +4.0% +3.4% +4.3% +4.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 2,582 492 492 351 12.2 19.1 Jan 31, 2024 J-GAAP
Jan - Mar, 2024 2,344 205 208 100 3.5 8.7 May 15, 2024 J-GAAP
Apr - Jun, 2024 2,395 397 398 289 10.1 16.6 Jul 31, 2024 J-GAAP
Jul - Sep, 2024 2,519 439 438 319 11.1 17.4 Oct 31, 2024 J-GAAP
Oct - Dec, 2024 2,751 479 479 349 12.2 17.4 Jan 31, 2025 J-GAAP
YoY +6.5% -2.6% -2.6% -0.6% -0.6%

Related Articles